Nick Allenby

950 total citations
24 papers, 674 citations indexed

About

Nick Allenby is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Nick Allenby has authored 24 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pharmacology and 8 papers in Genetics. Recurrent topics in Nick Allenby's work include Microbial Natural Products and Biosynthesis (13 papers), Genomics and Phylogenetic Studies (10 papers) and Bacterial Genetics and Biotechnology (8 papers). Nick Allenby is often cited by papers focused on Microbial Natural Products and Biosynthesis (13 papers), Genomics and Phylogenetic Studies (10 papers) and Bacterial Genetics and Biotechnology (8 papers). Nick Allenby collaborates with scholars based in United Kingdom, Australia and Poland. Nick Allenby's co-authors include Alister C. Ward, Jeff Errington, Colin R. Harwood, Zoltán Prágai, Giselda Bucca, Colin P. Smith, Emma Laing, Anil Wipat, Andrzej Kierzek and Alan C. Ward and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and Scientific Reports.

In The Last Decade

Nick Allenby

22 papers receiving 668 citations

Peers

Nick Allenby
Elke E. E. Noens Netherlands
Ellen P. Guthrie United States
Anne Lamsa United States
Kathrin Schirner United States
Tamzin Gristwood United Kingdom
Nick Allenby
Citations per year, relative to Nick Allenby Nick Allenby (= 1×) peers Bronislava Řežuchová

Countries citing papers authored by Nick Allenby

Since Specialization
Citations

This map shows the geographic impact of Nick Allenby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Allenby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Allenby more than expected).

Fields of papers citing papers by Nick Allenby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Allenby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Allenby. The network helps show where Nick Allenby may publish in the future.

Co-authorship network of co-authors of Nick Allenby

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Allenby. A scholar is included among the top collaborators of Nick Allenby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Allenby. Nick Allenby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayles, Jacqueline, Michael J. Hall, Joe Gray, et al.. (2025). The zinc bound form of the actinomycete derived natural product compound JBIR-141 induces a mitotic phenotype in fission yeast. Scientific Reports. 15(1). 39721–39721.
3.
Lewis, Richard A., Richard Hammond, Mark D. Wilkinson, & Nick Allenby. (2025). Technological developments driving industrial natural product discovery. Natural Product Reports. 42(9). 1507–1532.
4.
Watson, Andrew, Sahar Mubarak Bakhiet, Najwa A. Mhmoud, et al.. (2022). Systematic whole-genome sequencing reveals an unexpected diversity among actinomycetoma pathogens and provides insights into their antibacterial susceptibilities. PLoS neglected tropical diseases. 16(7). e0010128–e0010128. 5 indexed citations
5.
Dashti, Yousef, Corinne Wills, Emma C. L. Marrs, et al.. (2022). Discovery, isolation, heterologous expression and mode-of-action studies of the antibiotic polyketide tatiomicin from Amycolatopsis sp. DEM30355. Scientific Reports. 12(1). 15579–15579. 6 indexed citations
6.
Kim, Byung‐Yong, Peter Banks, Yousef Dashti, et al.. (2022). Mirubactin C rescues the lethal effect of cell wall biosynthesis mutations in Bacillus subtilis. Frontiers in Microbiology. 13. 1004737–1004737. 2 indexed citations
7.
Dashti, Yousef, et al.. (2022). Discovery of Demurilactone A: A Specific Growth Inhibitor of L-Form Bacillus subtilis. ACS Infectious Diseases. 8(11). 2253–2258. 2 indexed citations
8.
Green, Katherine, Juanjuan Li, Adam P. Hopkins, et al.. (2021). Screening and Purification of Natural Products from Actinomycetes that Induce a “Rounded” Morphological Phenotype in Fission Yeast. Natural Products and Bioprospecting. 11(4). 431–445. 4 indexed citations
9.
Molodtsov, Vadim, Christopher Moon, Rose E. Jeeves, et al.. (2018). Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis. Molecular Cell. 72(2). 263–274.e5. 46 indexed citations
10.
Ward, Alister C. & Nick Allenby. (2018). Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm. FEMS Microbiology Letters. 365(24). 61 indexed citations
11.
Lewis, Richard A., Juanjuan Li, Nick Allenby, et al.. (2017). Screening and purification of natural products from actinomycetes that affect the cell shape of fission yeast. Journal of Cell Science. 130(18). 3173–3185. 9 indexed citations
12.
Emami, Kaveh, Yoshikazu Kawai, Ling Juan Wu, et al.. (2017). RodA as the missing glycosyltransferase in Bacillus subtilis and antibiotic discovery for the peptidoglycan polymerase pathway. Nature Microbiology. 2(3). 16253–16253. 128 indexed citations
13.
Waddell, Paul G., Corinne Wills, William McFarlane, et al.. (2017). Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035. Journal of Natural Products. 80(5). 1558–1562. 25 indexed citations
14.
Probert, Michael R., W. Clegg, Corinne Wills, et al.. (2016). Production of 17-O-demethyl-geldanamycin, a cytotoxic ansamycin polyketide, by Streptomyces hygroscopicus DEM20745. Natural Product Research. 31(16). 1895–1900. 9 indexed citations
15.
Mısırlı, Göksel, Anil Wipat, Katherine James, et al.. (2013). BacillOndex: An Integrated Data Resource for Systems and Synthetic Biology. Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics. 10(2). 103–116. 10 indexed citations
16.
Allenby, Nick, Emma Laing, Giselda Bucca, Andrzej Kierzek, & Colin P. Smith. (2012). Diverse control of metabolism and other cellular processes in Streptomyces coelicolor by the PhoP transcription factor: genome-wide identification of in vivo targets. Nucleic Acids Research. 40(19). 9543–9556. 78 indexed citations
18.
Bucca, Giselda, Emma Laing, Vassilis Mersinias, et al.. (2009). Development and application of versatile high density microarrays for genome-wide analysis of Streptomyces coelicolor: characterization of the HspR regulon. Genome biology. 10(1). R5–R5. 29 indexed citations
19.
Allenby, Nick, et al.. (2005). Genome-Wide Transcriptional Analysis of the Phosphate Starvation Stimulon ofBacillus subtilis. Journal of Bacteriology. 187(23). 8063–8080. 66 indexed citations
20.
Prágai, Zoltán, Nick Allenby, Sarah Dubrac, et al.. (2004). Transcriptional Regulation of thephoPROperon inBacillus subtilis. Journal of Bacteriology. 186(4). 1182–1190. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026